Recombinant Apolipoprotein H (APOH) Homo sapiens (Human) Recombinant protein

Apo-H; B2G1; BG; B2-GP1; B2GP1; Autoantigen β2 GP I; Previously; Beta 2 Glycoprotein 1; APC inhibitor; Activated protein C-binding protein; Anticardiolipin cofactor; Beta-2-GPI

Add to Cart Distributors
Overview
Properties
  • Source Prokaryotic expression, Host E.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationSecreted
  • Molecular Mass 37.3kDa, Accurate 37kDa(Analysis of differences refer to the manual)
  • Residues & TagsThr22~Cys345 with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
  • Traits Freeze-dried powder, Purity > 97%
  • Isoelectric Point8.0
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Recombinant Apolipoprotein H (APOH) Packages (Simulation)
  • Recombinant Apolipoprotein H (APOH) Packages (Simulation)
  • Recombinant Apolipoprotein H (APOH) Figure . Gene Sequencing (extract)
  • RPA310Hu01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Sequence

Usage

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • Contamination of therapeutic human immunoglobulin preparations with apolipoprotein H (β2-glycoprotein I)Pubmed: 24132587
  • Beta2-Glycoprotein I in Hepatitis B virus infection patients with hepatocellular carcinoma, chronic hepatitis B and acute hepatitis Bfiles:ijcep0036317.pdf

Recommend products